Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
Apply
Sacituzumab Govitecan
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step